BioXcel Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
MEHTA VIMAL director, 10 percent owner, off..
Common Stock 358 $8.44 $3,022
Purchase
YOCCA FRANK officer: Chief Scientific Officer
Common Stock 6,547 $8.67 $56,762
Purchase
MEHTA VIMAL director, 10 percent owner, off..
Common Stock 1,000 $8.75 $8,750
Purchase
MEHTA VIMAL director, 10 percent owner, off..
Common Stock 2,000 $4.41 $8,824
Purchase
MUELLER PETER director
Common Stock 7,400 $5.01 $37,037
Purchase
MUELLER PETER director
Common Stock 1,395 $5.01 $6,982
Purchase
MEHTA VIMAL director, 10 percent owner, off..
Common Stock 1,000 $5.15 $5,150
Purchase
MUELLER PETER director
Common Stock 4,007 $5.12 $20,516
Purchase
YOCCA FRANK officer: Chief Scientific Officer
Common Stock 450 $5.2 $2,339
Purchase
STEINHART RICHARD I officer: Chief Financial Officer
Common Stock 500 $5.2 $2,600
Purchase
YOCCA FRANK officer: Chief Scientific Officer
Common Stock 450 $5.2 $2,339
Purchase
MEHTA VIMAL director, 10 percent owner, off..
Common Stock 1,000 $5.17 $5,168
Purchase
STEINHART RICHARD I officer: Chief Financial Officer
Common Stock 500 $5 $2,500
Purchase
YOCCA FRANK officer: Chief Scientific Officer
Common Stock 450 $5.2 $2,340
Purchase
MEHTA VIMAL director, 10 percent owner, off..
Common Stock 1,000 $5.19 $5,193
Purchase
NANDABALAN KRISHNAN director, 10 percent owner
Common Stock 1,000 $4.92 $4,915
Purchase
STEINHART RICHARD I officer: Chief Financial Officer
Common Stock 500 $5 $2,500
Purchase
YOCCA FRANK officer: Chief Scientific Officer
Common Stock 500 $5.02 $2,511

Showing 250 to 268 of 268 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.